News

News

PublISHED ON

UpDATED ON

10 million SEK to national study of COVID-19

The Swedish Research Council is providing 10 million SEK to fund the ImmCoVA clinical study. The study is expected to run for three years, and focuses on immune blockers to counteract excess reaction of the immune system to the infection caused by COVID-19.

Foto: Chris McLay, Unsplash

In June, we reported that the Swedish Research Council was to fund Sweden’s participation in the Solidarity trial, a major clinical WHO study, where a number of antiviral medicines are tested on patients being treated for COVID-19. However, due to the high level of mortality seen in patients receiving some of these medicines, the Swedish network for the WHO study decided that Sweden would not participate in the study.

Instead, the Swedish Research Council is now providing the same network of infection clinics in Sweden with funding of 10 million SEK to conduct another national study into COVID-19. The study is called ImmCoVA, and is expected to run for three years, starting in October. The study focuses on immune blockers to counteract excess reaction of the immune system to infection, known as ‘cytokine storm’. The study will investigate whether treatment with two specific immunosuppressing substances can result in improvement, and at best in patients recovering more quickly than with standard treatments.

The Karolinska University Hospital is leading the study, and patients will be recruited from five university hospitals.

PUBLISHED ON

UpDATED ON

MORE WITHIN THE SAME SUBJECT AREA

  1. Research overview for medicine and health

    You are now able to comment on the contents of the preliminary research overview for medicine and health. Please read the instructions and submit your comments no later than 12 October.

  2. Research overview for clinical therapy research

    You are now able to comment on the contents of the preliminary research overview for clinical therapy research. Please read the instructions and submit your comments no later than 12 October.

  3. The Swedish Research Council establishes national support and advice on health data

    Increased knowledge, national coordination and regular mappings of unclear areas and obstacles. This is the way forward for improving the utilisation of health data for research and innovation. We are now beginning the work of establishing national s...